Loading…

Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload

Currently it is not certain whether hypertrophy or the underlying disease is the primary trigger of the alterations in early gene expression in the progression of cardiac disease to end‐stage heart failure. In this study, we tested the notion that in left ventricular overload disorders, the changes...

Full description

Saved in:
Bibliographic Details
Published in:Fundamental & clinical pharmacology 2004-02, Vol.18 (1), p.39-44
Main Authors: Dzimiri, Nduna, Al-Bahnasi, Kholod, Al-Halees, Zohair
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Currently it is not certain whether hypertrophy or the underlying disease is the primary trigger of the alterations in early gene expression in the progression of cardiac disease to end‐stage heart failure. In this study, we tested the notion that in left ventricular overload disorders, the changes in early gene expression in the progression to heart failure is independent of the manifestation of cardiac hypertrophy. We compared the expression of the early genes c‐fos, c‐myc, and c‐jun in six dilated cardiomyopathic hearts (DCM) and 15 patients with left ventricular volume overload (VOL) resulting from mitral/aortic regurgitation and no significant stenosis or hypertrophic manifestations, using eight healthy donor hearts as controls. In VOL, c‐myc was elevated by 88% (P 
ISSN:0767-3981
1472-8206
DOI:10.1046/j.0767-3981.2003.00212.x